Evidence map›Paper›PMID 39485277›Full record

ArticleeLife2024

A scenario for an evolutionary selection of ageing.

Tristan Roget, Claire Macmurray, Pierre Jolivet, Sylvie Meleard, Michael Rera

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tristan RogetInstitut Montpelliérain Alexander Grothendieck (IMAG), Université de Montpellier, Montpellier, France.
Claire MacmurrayUniversité Paris Cité, Paris, France.
Pierre JolivetSorbonne Université, CNRS, Paris, France.
Sylvie MeleardInstitut Universitaire de France et École Polytechnique, CNRS, Institut polytechnique de Paris, Palaiseau, France.
Michael ReraUniversité Paris Cité, Institut Jacques Monod, Paris, France.ORCID https://orcid.org/0000-0002-6574-6511

Funding

Agence Nationale de la Recherche ANR-20-CE44-0010European Research Council SINGER 101054787TGCC@CEA A0090607519Veolia Environnement - Ecole Polytechnique - Museum d'Histoire Naturelle - Fondation X Chair "Modélisation Mathématique et Biodiversité"
6 · The paper itself

Abstract

Signs of ageing become apparent only late in life, after organismal development is finalized. Ageing, most notably, decreases an individual's fitness. As such, it is most commonly perceived as a non-adaptive force of evolution and considered a by-product of natural selection. Building upon the evolutionarily conserved age-related Smurf phenotype, we propose a simple mathematical life-history trait model in which an organism is characterized by two core abilities: reproduction and homeostasis. Through the simulation of this model, we observe (1) the convergence of fertility's end with the onset of senescence, (2) the relative success of ageing populations, as compared to non-ageing populations, and (3) the enhanced evolvability (i.e. the generation of genetic variability) of ageing populations. In addition, we formally demonstrate the mathematical convergence observed in (1). We thus theorize that mechanisms that link the timing of fertility and ageing have been selected and fixed over evolutionary history, which, in turn, explains why ageing populations are more evolvable and therefore more successful. Broadly speaking, our work suggests that ageing is an adaptive force of evolution.

Indexed as

AgingBiological EvolutionSelection, GeneticAnimalsFertilityHumansadaptabilityageing evolutiondifferential inclusionevolutionary biologynonetwo phases model

Identifiers

PMID39485277
PMCPMC11530237

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.